ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
BNP 및 NT-proBNP 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에 CAGR은 12.2%를 나타낼 것으로 예측되고 35억 9,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 심혈관 질환 부담 증가, 현장 진단(POCT) 통합, 기타 질환 분야에서의 확대된 용도, 맞춤형 의약품 접근법, 원격의료 및 원격 모니터링 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 분석 방법의 기술적 발전, 맞춤형 의약품 접근법, 예후 예측을 위한 바이오마커 활용, 새로운 바이오마커의 등장, 전 세계 표준화 노력 등이 있습니다.
향후 5년간 12.2% 성장이라는 예측은 이전 전망 대비 0.1% 소폭 하향 조정된 수치입니다. 이 하향 조정은 주로 미국과 타국 간 관세 부과 영향 때문입니다. 관세 부과로 인해 독일 및 스위스에서 수입되는 심부전 바이오마커 검사 및 현장진단기기(POCT) 비용이 증가하여 미국 심장학 진단 시장이 교란될 수 있으며, 이는 진단 지연 및 심장 검사실 비용 증가로 이어질 수 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 파급 효과는 더욱 광범위해질 것입니다.
향후 심혈관 질환 발생률 증가가 BNP 및 NTproBNP 시장 성장을 촉진할 것으로 예상됩니다. 심혈관 질환은 말초동맥질환, 뇌혈관질환, 관상동맥질환 등 심장과 혈관에 영향을 미치는 질환을 포함됩니다. BNP 및 NTproBNP 시험은 심장 건강 및 안전에 주력하여, 발병 전 심혈관 질환 유발 요인을 식별함으로써 예방 조치 시행과 사망 위험 감소를 지원합니다. 예를 들어 2024년 5월 미국 정부기관인 질병관리예방센터(CDC)는 심혈관질환과 관련된 사망이 33초에 1명 발생했으며, 2022년에 심장질환이 70만 2,880명(사망자 수의 약 5명 중 1명)을 차지한다고 보고했습니다. 심혈관 질환의 이환율 증가는 BNP 및 NT-proBNP 시장을 추진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 BNP 및 NT-proBNP : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 BNP 및 NT-proBNP 시장 : 성장률 분석
세계의 BNP 및 NT-proBNP 시장 실적 : 규모와 성장(2019-2024년)
세계의 BNP 및 NT-proBNP 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 BNP 및 NT-proBNP : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 BNP 및 NT-proBNP 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
BNP(뇌 나트륨 이뇨 펩티드)
NT-proBNP(N-말단 프로-B형 나트륨 이뇨 펩티드)
세계의 BNP 및 NT-proBNP 시장 검사 장소별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
현장 진단 검사(POCT)
임상 검사
세계의 BNP 및 NT-proBNP 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
심근경색
울혈성 심부전
급성관 증후군(ACS)
기타 용도
세계의 BNP 및 NT-proBNP 시장, BNP 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
BNP 검사 키트
현장 검사 BNP 검사 장치
실험실 BNP 분석
세계의 BNP 및 NT-proBNP 시장, NT-ProBNP 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
NT-ProBNP 검사 키트
현장 검사 NT-proBNP 검사 장치
실험실 NT-ProBNP 분석
세계의 BNP 및 NT-proBNP 시장, 서비스 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
컨설팅 서비스
통합 서비스
지원 및 유지보수 서비스
트레이닝 서비스
제7장 지역별 및 국가별 분석
세계의 BNP 및 NT-proBNP 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 BNP 및 NT-proBNP 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
BNP 및 NT-proBNP 시장 : 경쟁 구도
BNP 및 NT-proBNP 시장 : 기업 프로파일
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Gentian Diagnostics ASA : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens AG : 개요, 제품 및 서비스, 전략 및 재무 분석
PerkinElmer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Biomerieux SA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Quidel Corporation
Bio-Rad Laboratories Inc.
F Hoffman La Roche Ltd.
CTK Biotech Inc.
RayBiotech Life Inc.
BHR Pharmaceuticals Ltd.
Getein Biotech Inc.
VACURE Biotechnology Co. Ltd.
Bio-Techne Co.
Xiamen Biotime Biotechnology Co. Ltd.
Scripps Laboratories Inc.
Danaher Corporation
Beckman Coulter Inc.
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
BNP 및 NT-proBNP 시장(2029년) : 새로운 기회를 제공하는 국가
BNP 및 NT-proBNP 시장(2029년) : 새로운 기회를 제공하는 부문
BNP 및 NT-proBNP 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) tests are diagnostic assessments gauging the levels of either BNP or its precursor hormone NT-proBNP in the blood. These tests serve as indicators for heart failure and various cardiac conditions. BNP and NT-proBNP, categorized as natriuretic peptides, hold pivotal roles in regulating circulation. Elevated levels of BNP or NT-proBNP typically signify underlying heart disease, specifically abnormalities in blood pumping.
These tests primarily involve measuring the quantities of BNP (brain natriuretic peptide) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) in the bloodstream. The BNP test specifically targets BNP levels, aiding in the detection of heart failure and other cardiac conditions. Testing locations encompass both point-of-care and laboratory settings, facilitating diagnostics for myocardial infarction, congestive heart failure, acute coronary syndrome (ACS), and other related ailments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The BNP and NTproBNP market research report is one of a series of new reports from The Business Research Company that provides BNP and NTproBNP market statistics, including the BNP and NTproBNP industry global market size, regional shares, competitors with a BNP and NTproBNP market share, detailed BNP and NTproBNP market segments, market trends, and opportunities, and any further data you may need to thrive in the BNP and NTproBNP industry. This BNP and NTproBNP market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bnp and ntprobnp market size has grown rapidly in recent years. It will grow from $2.01 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to aging population, clinical utility in heart failure diagnosis, advancements in cardiovascular medicine, focus on preventive healthcare.
The bnp and ntprobnp market size is expected to see rapid growth in the next few years. It will grow to $3.59 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in other medical conditions, personalized medicine approaches, telemedicine and remote monitoring. Major trends in the forecast period include technological advancements in assay methods, personalized medicine approaches, biomarker in predicting prognosis, emergence of novel biomarkers, global standardization efforts.
The forecast of 12.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cardiology diagnostics by increasing costs for heart failure biomarker tests and point-of-care analyzers imported from Germany and Switzerland, potentially prolonging diagnosis and raising cardiac lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing occurrence of cardiovascular diseases is anticipated to drive the growth of the BNP and NTproBNP market in the future. Cardiovascular diseases encompass conditions that impact the heart and blood vessels, including peripheral arterial disease, cerebrovascular disease, and coronary heart disease, among others. Tests for BNP and NTproBNP focus on monitoring heart health and safety, identifying factors that contribute to cardiovascular disease prior to its onset, which aids in implementing preventive measures and lowering the risk of mortality. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a government agency in the US, reported that a death related to cardiovascular disease occurs every 33 seconds, with heart disease accounting for 702,880 deaths in 2022-roughly one in five fatalities. The growing incidence of cardiovascular diseases is propelling the BNP and NTproBNP markets.
The expanding geriatric demographic is anticipated to be a driving force for the BNP and NTproBNP market's expansion. This segment, comprising individuals aged 65 or older, finds critical assistance from BNP and NTproBNP tests in diagnosing and managing heart failure. These biomarkers provide valuable insights into cardiac function, aiding in tailored treatment strategies for elderly individuals. The World Health Organization reports that by 2030, one in six individuals globally will be 60 or older, projected to reach 2.1 billion elderly individuals by 2050. Hence, the burgeoning geriatric population propels the growth of the BNP and NTproBNP market.
Innovation in product development emerges as a significant trend driving the BNP and NTproBNP markets. Leading companies in these markets prioritize introducing novel products to maintain their market positions. For instance, in May 2023, Randox Laboratories unveiled a BNP1-32 diagnostic test for heart failure diagnosis. This automated test measures BNP levels with high sensitivity and specificity, integrating with third-party controls and software for effective QC data monitoring. This control ensures accurate and reliable BNP testing.
Prominent companies in the BNP and NTproBNP market are intensifying their focus on rapid screening bioassays to gain a competitive edge. Rapid screening bioassays efficiently assess substance presence or concentration by measuring effects on living cells or organisms, aiding in swift and reliable attribute identification or condition categorization. Mindray Medical International Limited, in October 2023, introduced two new assays-high-sensitivity troponin I (hs-cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP). These assays bolster Mindray's ability to screen, risk-stratify, diagnose rapidly, and monitor therapy for cardiovascular diseases, enhancing their portfolio for efficient disease management. Mindray's collaboration with HyTest further strengthens its immunoassay platforms, integrating advanced research and antibodies for cardiac biomarkers.
In July 2024, Roche Holding AG, a pharmaceutical and diagnostics company based in Switzerland, acquired LumiraDx Limited for an undisclosed sum. This acquisition is intended to strengthen Roche's diagnostics portfolio by incorporating advanced point-of-care technology that facilitates quick testing for BNP and NT-proBNP. LumiraDx Limited, located in the UK, is known for its innovative rapid test for NT-proBNP.
Major companies operating in the bnp and ntprobnp market include Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., F Hoffman La Roche Ltd., CTK Biotech Inc., RayBiotech Life Inc., BHR Pharmaceuticals Ltd., Getein Biotech Inc., VACURE Biotechnology Co. Ltd., Bio-Techne Co., Xiamen Biotime Biotechnology Co. Ltd., Scripps Laboratories Inc., Danaher Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., LSI Medience Corporation, Shionogi & Co. Ltd., Radiometer Medical ApS, Ortho Clinical Diagnostics, Tosoh Corporation, Aidian Oy, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Becton Dickinson and Company, Acon Laboratories Inc., Response Biomedical Corp., Nanomix Inc., Cepheid Inc., Alere Inc.
Asia-Pacific was the largest region in the BNP and NTproBNP market in 2024. North America is expected to be the fastest-growing region in the global BNP and NTproBNP market report during the forecast period. The regions covered in the bnp and ntprobnp market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the bnp and ntprobnp market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The BNP and NTproBNP market includes revenues earned by companies by providing diagnostic and heart disease detection services using BNP (B-type natriuretic peptide) or NT-proBNP (N-terminal Pro-brain Natriuretic Peptide) as biomarkers, BNP and NTproBNP assays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
BNP And NTproBNP Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bnp and ntprobnp market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bnp and ntprobnp ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bnp and ntprobnp market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. BNP And NTproBNP Market Characteristics
3. BNP And NTproBNP Market Trends And Strategies
4. BNP And NTproBNP Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global BNP And NTproBNP Growth Analysis And Strategic Analysis Framework
5.1. Global BNP And NTproBNP PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global BNP And NTproBNP Market Growth Rate Analysis
5.4. Global BNP And NTproBNP Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global BNP And NTproBNP Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global BNP And NTproBNP Total Addressable Market (TAM)
6. BNP And NTproBNP Market Segmentation
6.1. Global BNP And NTproBNP Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
